BioSpace News Archive

Business

TGaS Promotes Staab to SVP, Emerging Life Sciences Network

TGaS Advisors announced the promotion of Curt Staab to Senior Vice President, Emerging Life Sciences Network (elsN). A division of TGaS, elsN is a membership organization for emerging and pre-commercial life sciences companies.

October 24, 2017

·

2 min read

Pharm Country

AAlmac Group Introduces Accountability and Reconciliation Tracking Fully Configurable Extension of IXRS3 Provides End-to-End Traceability of IMP

Almac Clinical Technologies, a global leader in technology-enabled solutions for managing clinical trial patient and supplies data, has extended the functionality of its industry-leading IXRS 3 IRT platform to include Accountability and Reconciliation Tracking (ART).

October 24, 2017

·

3 min read

ARTES Receives French Research Tax Credit (CIR) Accreditation

The French R&D tax credit CIR gives French companies the ability to claim tax relief on 30% on all generated costs outsourced to ARTES’ R&D services.

October 24, 2017

·

1 min read

Lone Star Bio

Halas Wins American Physical Society’s Lilienfeld Prize

The American Physical Society (APS) has awarded Rice University nanoscientist Naomi Halas the prestigious 2018 Julius Edgar Lilienfeld Prize.

October 24, 2017

·

3 min read

Drug Manufacturers and the New FDA Drug Listing Rules - a Primer From Data Conversion Laboratory

Data Conversion Laboratory (DCL) is offering a free webinar on October 26 at 1:00pm ET to explain the new FDA drug listing rules, which will be affecting all U.S. drug listings.

October 24, 2017

·

2 min read

Biotech Beach

Biogennix Ramps Up National Distribution for Bone Graft Substitute Products osteoSPAN and Morpheus

Irvine-based Biogennix announced today that it is expanding its distribution efforts for its novel bone graft substitutes, Morpheus and osteoSPAN to full national distribution.

October 24, 2017

·

1 min read

Drug Development

Wilson Therapeutics Reaches Agreement With The FDA And EMA To Initiate Pivotal Phase 3 FOCuS study With WTX101 in Wilson Disease

Wilson Therapeutics (publ) today announced that the discussions with the FDA and the EMA, regarding the study protocol for the single pivotal Phase 3 FOCuS trial for WTX101 in Wilson Disease, have been concluded successfully.

October 24, 2017

·

7 min read

METTLER TOLEDO Launches New InMotion KF Oven Autosamplers Product Line

METTLER TOLEDO is pleased to announce the launch of its brand-new, fully certified InMotion KF Oven Autosamplers: InMotion Flex and InMotion Pro.

October 24, 2017

·

2 min read

Policy

Moleculin Requests Authorization From the Polish Government to Advance Annamycin

Moleculin Biotech announced that has submitted its request for Clinical Trial Authorization (“CTA”) in Poland which, if allowed, will enable a clinical trial to study Annamycin for the treatment of relapsed or refractory acute myeloid leukemia (“AML”) in Poland.

October 24, 2017

·

1 min read

Drug Development

Dimerix Receives Ethics Committee Approval in Australia for Pharmacokinetic Trial of New Extended Release Formulation

Dimerix Limited, is pleased to announce that it has received ethics committee approval for a study in healthy volunteers to determine the pharmacokinetic properties of the novel extended release propagermanium tablet to be used in the Company’s DMX-200 Phase 2b trial in Chronic Kidney Disease.

October 24, 2017

·

3 min read